The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Feb 20, 2025
0
0
Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high morbidity and mortality worldwide. In affected people, insulin is unable to facilitate the uptake of ...
Feb 19, 2025
0
0
Marked variation in the prevalence of depression was found in a multisite sample of community-dwelling older adults in the United States, reports a study by Columbia University Mailman School of Public Health. Until now, ...
Jan 8, 2025
0
0
Liggins Institute in Auckland-led research has found that adults who were born preterm showed no statistically significant differences in diabetes, prediabetes, or dyslipidemia and had fewer cardiovascular events compared ...
Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 in the Journal of Clinical ...
Dec 22, 2024
0
0
Walking speed can provide insights into health, extending beyond mere mobility, so much so that it is considered to be the "sixth vital sign." Past studies have suggested that a slow walking speed is correlated with the development ...
Dec 19, 2024
0
1
A fully automated algorithm to quantify aortic artery calcification (AAC) on computed tomography (CT) scans performed for other clinical purposes (opportunistic CT) can predict the risk for subsequent major adverse cardiovascular ...
Dec 10, 2024
0
1
A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their first year of life.
Nov 19, 2024
0
0
A competitive swimming program developed by University of Queensland researchers for young people with severe cerebral palsy has reversed motor decline associated with the condition.
Nov 19, 2024
0
20
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according to a study scheduled for presentation ...
Nov 14, 2024
0
0
